Camp4 Therapeutics (CAMP) Retained Earnings (2023 - 2026)

Camp4 Therapeutics has disclosed Retained Earnings across 4 years of filings, most recently posting -$310.5 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$310.5 million, down 38.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$310.5 million (down 38.5% YoY), and the FY2025 annual result was -$292.2 million, down 37.97% from the prior year.
• Retained Earnings came in at -$310.5 million for Q1 2026 at Camp4 Therapeutics, down from -$292.2 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$160.0 million in Q4 2023 to a low of -$310.5 million in Q1 2026.
• The 4-year median for Retained Earnings is -$230.5 million (2025), against an average of -$235.7 million.
• Across the five-year window, Retained Earnings slipped 26.92% in 2025 and sank 38.5% in 2026, its largest moves.
• Camp4 Therapeutics' Retained Earnings stood at -$160.0 million in 2023, then plunged by 32.38% to -$211.8 million in 2024, then slumped by 37.97% to -$292.2 million in 2025, then slipped by 6.28% to -$310.5 million in 2026.
• The last three Retained Earnings figures came in at -$310.5 million (Q1 2026), -$292.2 million (Q4 2025), and -$251.9 million (Q3 2025), per Business Quant data.